German Biotech Firm TeGenero AG Files For Insolvency

By Ben Hirschler and Astrid Zweynert--LONDON, July 4 (Reuters) - German biotechnology company TeGenero AG, which made a drug that left six men seriously ill when a clinical trial went badly wrong in Britain earlier this year, filed for insolvency on Tuesday. Privately owned TeGenero submitted the filing in the Bavarian city of Wuerzburg after failing to attract investment necessary for the company to continue operating, it said in a statement on its Web site (www.tegenero.com).